SCYNEXIS, Inc. IPO Research Information

SCYNEXIS, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on SCYNEXIS, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
SCYNEXIS, Inc.	SCYX - NASDAQ	$10.00-$10.00	$10.00	$9.75	6.2 million	5/2/2014
Underwriter(s): RBC Capital Markets, Canaccord Genuity
Co-Manager(s): JMP Securities
Industry: Health Care
Filing(s): Filed 2014-02-27 Terms Added 2014-03-19 Terms Added 2014-04-30

SCYNEXIS, Inc. Quote & Chart - Click for current quote - SCYX

About SCYNEXIS, Inc. (adapted from SCYNEXIS, Inc. prospectus):
They are a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "SCYX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.